(Q41055645)

26 September 2017

title

Seroepidemiology of hepatitis B virus infection in 2 million men aged 21-49 years in rural China: a population-based, cross-sectional study (English)

1 reference

26 September 2017

0 references

1 reference

1 reference

4

Haiping Shen

1 reference

26 September 2017

3

Qiaomei Wang

1 reference

26 September 2017

Jue Liu

1

1 reference

26 September 2017

Shikun Zhang

2

1 reference

26 September 2017

Man Zhang

5

1 reference

26 September 2017

Yiping Zhang

6

1 reference

26 September 2017

Donghai Yan

7

1 reference

26 September 2017

Min Liu

8

1 reference

26 September 2017

publication date

7 August 2015

1 reference

Lancet Infectious Diseases

26 September 2017

published in

1 reference

26 September 2017

volume

16

1 reference

26 September 2017

issue

1

1 reference

26 September 2017

page(s)

80-86

1 reference

Hepatitis B virus infection

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900218-2

7 January 2021

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900218-2

7 January 2021

Epidemiology of hepatitis B and C viruses: a global overview

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900218-2

7 January 2021

Update on epidemiology of hepatitis B and C in China

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900218-2

7 January 2021

The global burden of liver disease: the major impact of China

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900218-2

7 January 2021

Assessment of total economic burden of chronic hepatitis B (CHB)-related diseases in Beijing and Guangzhou, China

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900218-2

7 January 2021

Epidemiology and prevention of hepatitis B virus infection in China

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900218-2

7 January 2021

Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900218-2

7 January 2021

Hepatitis B surface antigen prevalence among 12,393 rural women of childbearing age in Hainan Province, China: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900218-2

7 January 2021

Prevalence of hepatitis B in the southeast of China: a population-based study with a large sample size

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900218-2

7 January 2021

General Epidemiological Parameters of Viral Hepatitis A, B, C, and E in Six Regions of China: A Cross-Sectional Study in 2007

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900218-2

7 January 2021

Age-specific prevalence of hepatitis B virus infection in young pregnant women, Hong Kong Special Administrative Region of China

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900218-2

7 January 2021

The estimation of prevalence, incidence, and residual risk of transfusion-transmitted human hepatitis B infection from blood donated at the Anhui blood center, China, from 2009 to 2011

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900218-2

7 January 2021

The prevalence and risk factors of hepatitis B virus infection in an adult population in Romania: a nationwide survey

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900218-2

7 January 2021

Seroprevalence of hepatitis B and immune response to hepatitis B vaccination in Chinese college students mainly from the rural areas of western China and born before HBV vaccination integrated into expanded program of immunization

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900218-2

7 January 2021

Key outcomes and addressing remaining challenges--perspectives from a final evaluation of the China GAVI project

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900218-2

7 January 2021

Hepatitis B vaccination coverage rates among adults in rural China: are economic barriers relevant?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900218-2

7 January 2021

The prevalence of hepatitis B virus infection in the United States in the era of vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900218-2

7 January 2021

Vertical Transmission of Hepatitis B Antigen in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900218-2

7 January 2021

Successful promotion of hepatitis B vaccinations among Vietnamese-American children ages 3 to 18: results of a controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900218-2

7 January 2021

10.1016/S1473-3099(15)00218-2

Identifiers

DOI

1 reference

26 September 2017

1 reference